LEONARD J HARRIS
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology GERMANTOWN, TN NPI 1518014307
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology TN PFIZER INC. All categories
General Payments — all program years on this page
$3,546.93
- Category: General Payments
- Program years: PY2019–2024
- Record count: 97
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,275.33 across 47 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,125.33 | 46 |
| Consulting Fee | $150.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $223.20 | 5 |
| Janssen Biotech, Inc. | $164.82 | 8 |
| Gilead Sciences, Inc. | $136.42 | 5 |
| Amgen Inc. | $101.62 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $76.50 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $74.00 | 4 |
| Lilly USA, LLC | $56.20 | 2 |
| EISAI INC. | $49.40 | 2 |
| Daiichi Sankyo Inc. | $45.84 | 2 |
| Merck Sharp & Dohme Corporation | $42.52 | 2 |
| Astellas Pharma US Inc | $32.13 | 1 |
| Acrotech Biopharma Inc. | $31.40 | 1 |
| SOBI, INC | $30.83 | 1 |
| E.R. Squibb & Sons, L.L.C. | $30.47 | 2 |
| Kyowa Kirin, Inc. | $27.38 | 1 |
| GENZYME CORPORATION | $24.98 | 1 |
| Genmab U.S., Inc. | $24.52 | 1 |
| GlaxoSmithKline, LLC. | $23.43 | 1 |
| Celgene Corporation | $22.83 | 1 |
| BeiGene USA, Inc. | $21.51 | 1 |
| PharmaEssentia USA Corporation | $17.89 | 1 |
| Genentech USA, Inc. | $17.44 | 1 |
By program year
Records — PY2024 (47)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.